Trial Design Webinars

  1. Reducing The Burden Of PMC/PMR Studies For Sponsors, Sites, And Patients 8/19/2024

    VP of Research Oncology, Neal Meropol, MD, shares how a pragmatic approach to postmarketing commitments and postmarketing requirements can reduce the burden of these studies for sites and patients.

  2. Advancing CAR T-Cell Therapies With Clinical Trial Customization 8/8/2024

    Discover how to optimize your CAR T-cell therapy clinical trials with expert insights on genomics, flow cytometry, biomarkers, and clinical operations.

  3. Master Your Clinical Trial Budgets: A Step-By-Step Guide To Expense Planning 7/23/2024

    This webinar explains how to create and manage successful budgets, uncover and avoid hidden costs, and minimize the pandemic’s financial impact.

  4. ICH E9(R1) Addendum On Estimands And Sensitivity Analysis 7/23/2024

    Discover how the new framework will improve the way of designing and planning clinical trials and performing primary analyses and sensitivity analyses.

  5. Research As Care, A Patient Story 7/12/2024

    Witness Kirsten's remarkable journey unfold as she navigates a pivotal moment that ultimately saved her life.

  6. A Patient's Life-Changing Experience With Diabetes Research 7/12/2024

    Discover the inspiring journey of one man who battled diabetes and experienced a transformative shift in his life through a patient-focused clinical trial at the Elligo Clinical Research Center.

  7. The Real Reason Why You Should Participate In Clinical Research 7/12/2024

    Ruben, a news anchor from Laredo, Texas, provides a unique perspective as the inaugural participant in a COVID-19 vaccine trial, offering unprecedented insights into his daily experiences and motivations for joining clinical research.

  8. End-To-End Clinical Data Flow 6/24/2024

    Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.

  9. Feasibility Strategies For Research-Naïve Sites 6/13/2024

    Feasibility is not just a science, there’s also an art to it, says Nick Palumbo, director, feasibility and study start-up, at Takeda. In this clip he talks about how difficult it is for research sites with limited experience to get on a sponsors’ radar.

  10. Does The Feasibility Process Differ For Rare Diseases? 6/13/2024

    Mimi Ermens, senior director, clinical development operations, global feasibility and start-up support, at CSL Behring answers a question from the audience about whether there is a difference in how you should approach the feasibility process when dealing with rare diseases vs. common diseases.